We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

SA, which was left scrambling to source Covid-19 vaccines after failing to timeously place orders with manufacturers, is set to pay a massive premium on the shots it has secured directly from the Serum Institute of India (SII), the health department confirmed on Wednesday.

After weeks of growing criticism over the slow pace of its vaccine acquisition plans, the government announced in early January that it had secured 1.5-million doses of the SII’s Covishield shot, which the institute is manufacturing under licence from AstraZeneca. It has now emerged that the government has agreed to pay the SII $5.25 (about R78) a dose, more than twice the price the EU negotiated directly with AstraZeneca in 2020...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now